This HMO dispenses steroidal eye drops with nominal and almost equal co-payment, which ensures that all prescriptions were documented and that drug selection was not influenced by financial aspects. Since there is co-payment we assume that most of the medications that were filled were indeed used by the patients. The collection of data for the study was done anonymously and in conformity with all country laws and the declaration of Helsinki. The study was approved by the Institutional Review Board (Barzilai Medical Center).